Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma.

Eger, Katrien; Pet, Lodewijk; Weersink, Els J M; Bel, Elisabeth H

Eger, Katrien; Pet, Lodewijk; Weersink, Els J M; Bel, Elisabeth H.

Afiliação

Eger K; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: k.a.eger@amsterdamumc.nl.
Pet L; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Weersink EJM; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Bel EH; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

J Allergy Clin Immunol Pract ; 9(7): 2913-2915, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33676050

Assuntos

Anticorpos Monoclonais Humanizados; Asma; Corticosteroides/uso terapêutico; Asma/tratamento farmacológico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google